GTHX | Biotech Message Board Posts


Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  49005 of 50500  at  12/7/2023 4:50:23 PM  by

minxmrphd


 In response to msg 49004 by  zake1
view thread

Re: GTHX

It's being traded by the discord groups. This caught their eye on the 6th:
Live In Play®
Updated: 05-Dec-23 09:27 ET
GTHX: G1 Therapeutics presents new post hoc analyses indicating that patients who previously received Trilaciclib have improved overall survival with subsequent anticancer therapy (2.00)
- Analyses of Data from the Randomized Phase 2 Metastatic Triple Negative Breast Cancer (mTNBC) Trial Indicate That Prior Use of Trilaciclib with Cytotoxic Chemotherapy is Highly Correlated to Improved Long-Term Survival with Subsequent Anticancer Therapies -
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 3  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
49006 Re: GTHX Steve_382 5 12/7/2023 5:43:04 PM




Financial Market Data provided by
.
Loading...